BALAXI PHARMACEUTICALS
|
BALAXI PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10.00 Cr | ₹10.00 Cr |
| Equity - Authorised | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
| Equity - Issued | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10.00 Cr | ₹10.00 Cr |
| Equity Paid Up | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10.00 Cr | ₹10.00 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | ₹3.77 Cr | ₹10 Cr | - | - |
| Total Reserves | ₹221 Cr | ₹187 Cr | ₹162 Cr | ₹103 Cr | ₹55 Cr |
| Securities Premium | ₹57 Cr | ₹51 Cr | ₹19 Cr | ₹11 Cr | ₹11 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹163 Cr | ₹136 Cr | ₹143 Cr | ₹92 Cr | ₹44 Cr |
| General Reserves | ₹0.64 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr |
| Other Reserves | - | - | - | - | - |
| Reserve excluding Revaluation Reserve | ₹221 Cr | ₹187 Cr | ₹162 Cr | ₹103 Cr | ₹55 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹232 Cr | ₹201 Cr | ₹183 Cr | ₹113 Cr | ₹65 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | ₹21 Cr | - | ₹0.87 Cr | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | ₹21 Cr | - | ₹0.87 Cr | - | - |
| Deferred Tax Assets / Liabilities | ₹0.90 Cr | ₹1.00 Cr | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr |
| Deferred Tax Assets | ₹0.10 Cr | ₹0.11 Cr | - | - | - |
| Deferred Tax Liability | ₹1.00 Cr | ₹1.10 Cr | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr |
| Other Long Term Liabilities | ₹1.80 Cr | ₹1.74 Cr | ₹1.69 Cr | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹0.13 Cr | ₹0.04 Cr | - | - | - |
| Total Non-Current Liabilities | ₹24 Cr | ₹2.78 Cr | ₹3.66 Cr | ₹0.04 Cr | ₹0.01 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹16 Cr | ₹29 Cr | ₹35 Cr | ₹49 Cr | ₹25 Cr |
| Sundry Creditors | ₹16 Cr | ₹29 Cr | ₹35 Cr | ₹49 Cr | ₹25 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹4.61 Cr | ₹4.62 Cr | ₹2.81 Cr | ₹3.26 Cr | ₹0.14 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | - | - | - | - | - |
| Interest Accrued But Not Due | - | ₹0.01 Cr | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹4.61 Cr | ₹4.60 Cr | ₹2.81 Cr | ₹3.26 Cr | ₹0.14 Cr |
| Short Term Borrowings | ₹30 Cr | ₹18 Cr | ₹11 Cr | ₹3.64 Cr | ₹3.66 Cr |
| Secured ST Loans repayable on Demands | ₹0.05 Cr | ₹2.93 Cr | ₹4.99 Cr | ₹2.64 Cr | ₹0.33 Cr |
| Working Capital Loans- Sec | ₹0.05 Cr | ₹2.78 Cr | ₹4.42 Cr | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹30 Cr | ₹12 Cr | ₹1.34 Cr | ₹1.00 Cr | ₹3.33 Cr |
| Short Term Provisions | ₹3.37 Cr | ₹2.88 Cr | ₹5.06 Cr | ₹7.25 Cr | ₹6.01 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹3.37 Cr | ₹2.88 Cr | ₹5.06 Cr | ₹7.25 Cr | ₹6.01 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | - | - | - | - | - |
| Total Current Liabilities | ₹55 Cr | ₹54 Cr | ₹53 Cr | ₹63 Cr | ₹35 Cr |
| Total Liabilities | ₹310 Cr | ₹258 Cr | ₹240 Cr | ₹176 Cr | ₹100 Cr |
| ASSETS | |||||
| Gross Block | ₹43 Cr | ₹43 Cr | ₹44 Cr | ₹30 Cr | ₹2.75 Cr |
| Less: Accumulated Depreciation | ₹1.90 Cr | ₹2.10 Cr | ₹2.35 Cr | ₹0.76 Cr | ₹0.30 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹29 Cr | ₹2.45 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹22 Cr | ₹2.31 Cr | ₹2.83 Cr | ₹0.57 Cr | - |
| Non Current Investments | - | - | - | - | ₹3.42 Cr |
| Long Term Investment | - | - | - | - | ₹3.42 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | ₹3.42 Cr |
| Long Term Loans & Advances | ₹4.03 Cr | ₹4.58 Cr | ₹1.52 Cr | ₹1.27 Cr | ₹0.05 Cr |
| Other Non Current Assets | ₹0.50 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹4.87 Cr | - |
| Total Non-Current Assets | ₹68 Cr | ₹48 Cr | ₹46 Cr | ₹35 Cr | ₹5.91 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹78 Cr | ₹82 Cr | ₹105 Cr | ₹99 Cr | ₹14 Cr |
| Raw Materials | - | - | - | - | - |
| Work-in Progress | - | - | - | - | - |
| Finished Goods | - | - | - | - | - |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹78 Cr | ₹82 Cr | ₹105 Cr | ₹99 Cr | ₹14 Cr |
| Sundry Debtors | ₹111 Cr | ₹56 Cr | ₹52 Cr | ₹28 Cr | ₹77 Cr |
| Debtors more than Six months | ₹20 Cr | ₹10 Cr | ₹12 Cr | ₹13 Cr | - |
| Debtors Others | ₹91 Cr | ₹45 Cr | ₹40 Cr | ₹15 Cr | ₹77 Cr |
| Cash and Bank | ₹39 Cr | ₹62 Cr | ₹28 Cr | ₹7.19 Cr | ₹1.67 Cr |
| Cash in hand | ₹0.78 Cr | ₹1.79 Cr | - | ₹0.62 Cr | ₹0.05 Cr |
| Balances at Bank | ₹39 Cr | ₹61 Cr | ₹28 Cr | ₹6.57 Cr | ₹1.62 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹2.21 Cr | ₹2.02 Cr | ₹3.78 Cr | ₹3.90 Cr | ₹0.77 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹2.21 Cr | ₹2.02 Cr | ₹3.78 Cr | ₹3.12 Cr | ₹0.72 Cr |
| Other current_assets | - | - | - | ₹0.78 Cr | ₹0.05 Cr |
| Short Term Loans and Advances | ₹12 Cr | ₹7.99 Cr | ₹4.21 Cr | ₹3.65 Cr | ₹0.95 Cr |
| Advances recoverable in cash or in kind | ₹8.71 Cr | ₹6.42 Cr | ₹2.89 Cr | ₹2.37 Cr | ₹0.35 Cr |
| Advance income tax and TDS | - | - | - | ₹0.78 Cr | ₹0.61 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹3.17 Cr | ₹1.58 Cr | ₹1.32 Cr | ₹0.50 Cr | - |
| Total Current Assets | ₹243 Cr | ₹210 Cr | ₹194 Cr | ₹141 Cr | ₹94 Cr |
| Net Current Assets (Including Current Investments) | ₹188 Cr | ₹156 Cr | ₹140 Cr | ₹78 Cr | ₹59 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹310 Cr | ₹258 Cr | ₹240 Cr | ₹176 Cr | ₹100 Cr |
| Contingent Liabilities | - | - | - | - | - |
| Total Debt | ₹52 Cr | ₹18 Cr | ₹12 Cr | ₹3.64 Cr | ₹3.66 Cr |
| Book Value | - | 181.31 | 169.51 | 113.16 | 64.98 |
| Adjusted Book Value | 41.98 | 36.26 | 33.90 | 22.63 | 13.00 |
Compare Balance Sheet of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹232.2 Cr | -1.3% | -5.2% | -53.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹292,562.0 Cr | -2.2% | -3.2% | -12.1% | Stock Analytics | |
| REDINGTON | ₹20,576.3 Cr | -2.9% | -2.7% | 56.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,603.4 Cr | -5.4% | 2.6% | 57.8% | Stock Analytics | |
| MMTC | ₹10,320.0 Cr | -2.1% | -2.1% | -12.5% | Stock Analytics | |
| HONASA CONSUMER | ₹9,105.5 Cr | -2.8% | -8% | -32.3% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -1.3% |
-5.2% |
-53.5% |
| SENSEX | 0.3% |
3.6% |
5.5% |
You may also like the below Video Courses